ArticleNeurology and therapy2025

Lecanemab's Path Forward: Navigating the Future of Alzheimer's Treatment in Europe Amidst the EMA's Rejection.

Alessandro Martorana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.